Two agents representing a new class of oncology treatment entered the market at the end of 2014. With fast-tracked approvals in the fourth quarter, Merck’s Keytruda and BMS’s Opdivo were…

With the successful launch of the only monotherapy option in the HCV space, Gilead continues to have a strong hold on the Hepatitis C market. In contrast, AbbVie’s recent entry…

Synoma HealthCloud™ Offers Integrated Cloud-based Data Management for Pharmaceutical Clients HORSHAM, Pa., February 12, 2015 — Synoma Health Analytics, a provider of high-value market research, analytics and technology solutions for…

Clinical Registry Data Now Integrated with Rx and Health Care Claims to Offer Compelling New Insights to Improve Cardiac Care HORSHAM, Pa., and WASHINGTON, D.C. February 11, 2015 — Synoma…

Synoma Health Analytics’ Integrated Dataverse (IDV)™ shows that by mid-2013, more than half of all prescriptions in the U.S. were presented via electronic prescribing. Written prescriptions –- a piece of…